Ghisallo Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-100,000	Closed	-$2.97M	–	132
2023 Q3	$2.97M	Buy	+100,000	New	+$2.97M	0.3%	55